<p>1. What are Mesenchymal Stromal Cells? Origin and Discovery of Mesenchymal Stromal Cells<br>Jorge Domenech</p> <p>2. Mesenchymal Stem/Stromal Cells from Adult Tissues<br>Regina Coeli dos Santos Goldenberg, Debora Bastos Mello and Karina Dutra Asensi</p> <p>3. Mesenchymal Stem/Stromal Cells from Neonatal Tissues<br>Alp Can, Zeynep Gulhan Yigman</p> <p>4. Mesenchymal stem/Stromal Cells Derived from Pluripotent Stem Cells<br>Carlos Luzzani, Santiago G. Miriuka</p> <p>5. Mesenchymal Stem/Stromal Cells as Biological Factories <br>Addeli Bez Batti Angulski, Alejandro Correa, Marco Augusto Stimamiglio</p> <p>6. MSC recruitment from distant and local tissues in homeostasis and tissue remodeling<br>Lindolfo da Silva Meirelles, Nance Beyer Nardi</p> <p>7. Mesenchymal stem/stromal cell trafficking and homing<br>Armel Herve Nwabo Kamdje, Paul Faustin Seke Etet, Paul Takam Kamga, Jean Marc Muller, Giulio Bassi, Erique Lukong, Raghuveera Kumar Goel, Mauro Krampera</p> <p>8. Tumor-Secreted Factors That Induce Mesenchymal Stromal Cell Chemotaxis<br>Kevin Anton and John Glod</p> <p>9. Mesenchymal stromal cells recruitment by gastrointestinal carcinomas<br>Guillermo D. Mazzolini</p> <p>10. Mesenchymal Stem/Stromal Cell Recruitment by Central Nervous System Tumors<br>Brittany C. Parker Kerrigan and Frederick F. Lang</p> <p>11. Mesenchymal stem cell transition to tumor-associated stromal cells contributes to cancer progression<br>Karen M. Bussard,Erika Spaeth, Lysette A. Mutkus, Kristina A. Stumpf and Frank C. Marini</p> <p>12. Mesenchymal Stromal Cells and Tumor Angiogenesis<br>Shih-Chieh Hung</p> <p>13. Role of MSCs in Anti-Tumor Drug Resistance<br>Augustin Le Naour and Bettina Couderc</p> <p>14. Multifunctional Roles of Tumor-Associated Mesenchymal Stem Cells in Cancer Progression<br>Antoine E. Karnoub<br>15. Mesenchymal Stem Cells and Metastatic Niches<br>Leandro Marcelo Martinez, Vivian Labovsky, Valeria Beatriz Fernández Vallone, Choi Hosoon, Mariana Amorós, Casie Phillips and Norma Alejandra Chasseing</p> <p>16. The bone marrow microenvironment as a regulator of tumor dormancy<br>Makiko Ono and Takahiro Ochiya</p> <p>17. MSC and the tumor immune system<br>Nykia D. Walker, George R. Nahas, Jessian Munoz, Justin Lucas, Piotr Pobiarzyn and Pranela Rameshwar</p> <p>18. The inflammatory environment and its effects on mesenchymal stem cells<br>Krisztian Nemeth</p> <p>19. All Aboard: Mesenchymal Stem Cells as Cell Carriers for Virotherapy<br>Julius W. Kim, Jason Murphy, Alan L. Chang, DrewA. Spencer, J. Robert Kane,DeepakKanojia, Aida Rashidi, Jacob S. Young and Maciej S. Lesniak</p> <p>20. Engineered Mesenchymal Stem/ Stromal Cells for Cellular Therapies<br>Sreevidhya Ramakrishnan, Debanjan Sarkar</p> <p>21. Extracellular Vesicles from Mesenchymal Stem Cells and their potential in Tumor Therapy<br>Johann Mar Gudbergsson and Meg Duroux</p> <p>22. MSCs therapy: defining the risks of MSC therapy. Ex vivo expanded MSCs for therapeutic purposes<br>Myriam N. Bouchlaka, Peiman Hematti and Christian M. Capitini</p> <p>23. Concluding Remarks<br>Mariana Garcia and Marcela Bolontrade<br></p>
